Substituted N-bicyclo-2-aryl-quinolin-4-carboxamides and use thereof
申请人:BAYER PHARMA AKTIENGESELLSCHAFT
公开号:US10117864B2
公开(公告)日:2018-11-06
The present application relates to novel substituted N-bicyclo-2-arylquinoline-4-carboxamide derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of fibrotic and inflammatory disorders.
[DE] SUBSTITUIERTE N-BICYCLO-2-ARYLCHINOLIN-4-CARBOXAMIDE UND IHRE VERWENDUNG<br/>[EN] SUBSTITUTED N-BICYCLO-2-ARYL-QUINOLIN-4-CARBOXAMIDES AND USE THEREOF<br/>[FR] N-BICYCLO-2-ARYLCHINOLINO-4-CARBOXAMIDES SUBSTITUÉS ET LEUR UTILISATION
申请人:BAYER PHARMA AG
公开号:WO2016146602A1
公开(公告)日:2016-09-22
Die vorliegende Anmeldung betrifft neue substituierte N-Bicyclo-2-arylchinolin-4-carboxamid-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung allein oder in Kombinationen zur Behandlung und/oder Prävention von Krankheiten sowie ihre Verwendung zur Herstellung von Arzneimitteln zur Behandlung und/oder Prävention von Krankheiten, insbesondere zur Behandlung und/oder Prävention von fibrotischen und inflammatorischen Erkrankungen.
SUBSTITUTED N-BICYCLO-2-ARYL-QUINOLIN-4-CARBOXAMIDES AND USE THEREOF
申请人:BAYER PHARMA AKTIENGESELLSCHAFT
公开号:US20180036300A1
公开(公告)日:2018-02-08
The present application relates to novel substituted N-bicyclo-2-arylquinoline-4-carboxamide derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of fibrotic and inflammatory disorders.